Literature DB >> 11093769

Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil.

F Reimann1, F M Gribble, F M Ashcroft.   

Abstract

ATP-sensitive K-channels (K(ATP) channels) are the target for K(ATP)-channel openers (KCOs), such as pinacidil and P1075. These channels are formed from pore-forming Kir6.2 and regulatory sulfonylurea receptors (SUR2A in heart and skeletal muscle; SUR2B in smooth muscle). The two isoforms of SUR2 differ only in their final 42 amino acids, a region that includes neither the Walker A and B nucleotide binding motifs nor the proposed KCO binding site, yet channels containing SUR2A or SUR2B respond differently to both nucleotides and KCOs. We explored the basis for this difference by expressing Kir6.2/SUR2A and Kir6.2/SUR2B currents in Xenopus laevis oocytes. Kir6.2/SUR2B but not Kir6.2/SUR2A currents were activated by the Mg-nucleoside triphosphates MgATP and MgGTP, whereas both channel types responded to the diphosphates MgADP and MgGDP. This activation of Kir6.2/SUR2B currents by MgATP explains how the ATP concentration-response curve is shifted to the right in the presence of Mg(2+). In the absence of nucleotide, pinacidil and P1075 activated Kir6.2/SUR2B and Kir6.2/SUR2A currents, but the presence of nucleotide slowed the drug off-rates. In the presence of MgATP, the response to pinacidil reversed approximately 14 times more slowly with SUR2B than SUR2A. The EC(50) for ATP, measured by its ability to slow the pinacidil off-rate, was also approximately 20 times higher for channels containing SUR2A than SUR2B. Our findings suggest that nucleotide binding and/or hydrolysis is enhanced in SUR2B compared with SUR2A, and that the greater KCO-affinities of SUR2B compared with SUR2A may be a consequence of this altered nucleotide handling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093769     DOI: 10.1124/mol.58.6.1318

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

1.  Binding and effect of K ATP channel openers in the absence of Mg2+.

Authors:  Ulrich Russ; Ulf Lange; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

2.  Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.

Authors:  Frank Reimann; Michael Dabrowski; Phillippa Jones; Fiona M Gribble; Frances M Ashcroft
Journal:  J Physiol       Date:  2003-01-10       Impact factor: 5.182

Review 3.  Sulphonylurea action revisited: the post-cloning era.

Authors:  F M Gribble; F Reimann
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

Review 4.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 5.  ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart.

Authors:  Alexey E Alekseev; Denice M Hodgson; Amy B Karger; Sungjo Park; Leonid V Zingman; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-04-14       Impact factor: 5.000

6.  The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.

Authors:  Damian Stephan; Eva Stauss; Ulf Lange; Holger Felsch; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Russ; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

7.  Mutations in the linker domain of NBD2 of SUR inhibit transduction but not nucleotide binding.

Authors:  Michinori Matsuo; Michael Dabrowski; Kazumitsu Ueda; Frances M Ashcroft
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

Review 8.  Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator.

Authors:  Jussi Aittoniemi; Constantina Fotinou; Tim J Craig; Heidi de Wet; Peter Proks; Frances M Ashcroft
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

9.  Myorelaxant action of fluorine-containing pinacidil analog, flocalin, in bladder smooth muscle is mediated by inhibition of L-type calcium channels rather than activation of KATP channels.

Authors:  Igor B Philyppov; Andriy А Golub; Oleksiy I Boldyriev; Natalia L Shtefan; Khrystyna Totska; Oleg I Voitychuk; Yaroslav M Shuba
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-15       Impact factor: 3.000

10.  Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.

Authors:  Annette Hambrock; Cornelia Löffler-Walz; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.